Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Adicet Bio's Total Stockholders Equity for the quarter that ended in Dec. 2024 was $186.61 Mil. Adicet Bio's Total Assets for the quarter that ended in Dec. 2024 was $220.22 Mil.
The historical rank and industry rank for Adicet Bio's Equity-to-Asset or its related term are showing as below:
ACET'
s Equity-to-Asset Range Over the Past 10 Years
Min: -0.74 Med: 0.83 Max: 0.89
Current: 0.85
During the past 7 years, the highest Equity to Asset Ratio of Adicet Bio was 0.89. The lowest was -0.74. And the median was 0.83.
ACET's Equity-to-Asset is ranked better than 74.95% of 1505
companies
in the Biotechnology industry
Industry Median: 0.67
vs ACET: 0.85
Adicet Bio Equity-to-Asset Historical Data
The historical data trend for Adicet Bio's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Adicet Bio's Equity-to-Asset
For the Biotechnology subindustry, Adicet Bio's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Adicet Bio's Equity-to-Asset Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Adicet Bio's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Adicet Bio's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Adicet Bio's Equity to Asset Ratio for the fiscal year that ended in Dec. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Adicet Bio (NAS:ACET) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Adicet Bio Equity-to-Asset Related Terms
Thank you for viewing the detailed overview of Adicet Bio's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.
Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Its product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the potential treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. Their pipeline also includes its preclinical candidate, ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma, with potential for other CD70+ solid tumor and hematological malignancies indications.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ACET has been successfully added to your 